Alió J L, Artola A, Attia W H, Salem T F, Pérez-Santonja J J, Ayala M J, Claramonte P, Ruiz-Moreno J M
Instituto Oftalmológico de Alicante, Department of Refractive Surgery, Division of Ophthalmology, Miguel Hernandez University, Alicante, Spain.
Am J Ophthalmol. 2001 Aug;132(2):196-203. doi: 10.1016/s0002-9394(01)01004-2.
To evaluate the results of laser in situ keratomileusis after photorefractive keratectomy.
Eighty eyes of 80 patients with residual myopia after photorefractive keratectomy were reoperated with laser in situ keratomileusis. The study was retrospective. Laser in situ keratomileusis was performed using the automated corneal shaper microkeratome and Chiron Technolas 217-C d1 excimer laser. Data measured after laser in situ keratomileusis included uncorrected visual acuity, best-corrected visual acuity, refraction, haze, pachymetry, and keratometry. The follow-up was at least 12 +/- 1.6 months (range, 12 to 15 months).
After laser in situ keratomileusis the mean spherical equivalent was -0.24 diopters +/- 0.78. (range, -3 to +1.5) at 12 months, and the mean uncorrected visual acuity was 0.76 diopters +/- 0.24 (range, 0.1 to 1). Sixty-five eyes (81.3%) had various degrees of haze after laser in situ keratomileusis. One eye (1.2%) lost 2 lines of best-corrected visual acuity.
Laser in situ keratomileusis enhancement may be a good alternative to correct residual myopia and astigmatism after primary photorefractive keratectomy. Corneal haze is a common problem in these eyes, and the treatment after laser in situ keratomileusis enhancement should be the same as the treatment after primary photorefractive keratectomy.
评估准分子激光角膜切削术后准分子原位角膜磨镶术的效果。
对80例准分子激光角膜切削术后残留近视患者的80只眼行准分子原位角膜磨镶术。本研究为回顾性研究。使用自动角膜板层刀和Chiron Technolas 217 - C d1准分子激光进行准分子原位角膜磨镶术。准分子原位角膜磨镶术后测量的数据包括裸眼视力、最佳矫正视力、验光、角膜混浊、角膜厚度测量和角膜曲率测量。随访时间至少为12±1.6个月(范围12至15个月)。
准分子原位角膜磨镶术后12个月时,平均等效球镜度为-0.24屈光度±0.78(范围-3至+1.5),平均裸眼视力为0.76屈光度±0.24(范围0.1至1)。65只眼(81.3%)准分子原位角膜磨镶术后出现不同程度的角膜混浊。1只眼(1.2%)最佳矫正视力下降2行。
准分子原位角膜磨镶术增效术可能是矫正初次准分子激光角膜切削术后残留近视和散光的良好选择。角膜混浊是这些眼中的常见问题,准分子原位角膜磨镶术增效术后的治疗应与初次准分子激光角膜切削术后的治疗相同。